Helge Möllmann

Helge Möllmann

Interventional cardiologist / Cardiologist
St.-Johannes-Hospitals - Dortmund, Germany

Latest contributions

Are we undertreating aortic regurgitation?

20 May 2025 – From EuroPCR 2025

At EuroPCR 2025, Victoria Delgado, Helge Möllmann, and Dan Blackman gather to discuss a crucial but often under-addressed challenge in structural heart disease: the under-referral and under-treatment of patients with aortic regurgitation (AR).

The conversation begins with the diagnostic challenges surrounding severe AR, followed by a striking observation—only...

Are we undertreating aortic regurgitation?

Pushing the boundaries to optimise patient outcomes: from planning to success

26 Nov 2024 – From PCR London Valves 2024

Learn from experts about achieving optimal TAVI outcomes, tailoring approaches for lifetime management, and mastering tips for diverse anatomical challenges.

Pushing the boundaries to optimise patient outcomes: from planning to success

Zero-contrast TAVI while using a novel full-body embolic protection filter

26 Nov 2024 – From PCR London Valves 2024

Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.

Zero-contrast TAVI while using a novel full-body embolic protection filter

From index procedure to re-valving with a novel self-expanding valve

25 Nov 2024 – From PCR London Valves 2024

Watch this simulation-based symposium to explore the value of the Index Procedure in achieving optimal outcomes during the initial implant, crucial for preventing paravalvular leak, pacemaker dependency, and ensuring precise commissural alignment for coronary access. Discover how the ACURATE neo2/PRIME offers excellent coronary access with its...

From index procedure to re-valving with a novel self-expanding valve

Featured research - Aortic valve (Part 2)

24 Nov 2024 – From PCR London Valves 2024

This second part of the featured research session on aortic valve interventions delves into a wide range of topics, including vascular complications, valve-in-valve TAVI, coronary protection strategies, predictors of mortality, and innovative techniques. Discover the latest advancements and insights from cutting-edge research.

Featured research - Aortic valve (Part 2)

TAVI innovations: latest breakthroughs from PCR London Valves 2024

24 Nov 2024 – From PCR London Valves 2024

Curious about the latest advancements shaping the future of TAVI? Don't miss this video which deliver insights from the PCR London Valves 2024 Late-Breaking Trials, diving into key topics that matter most in clinical practice.

Explore 5-year outcomes of AVR in low-risk patients stratified by annulus size,...

TAVI innovations: latest breakthroughs from PCR London Valves 2024

Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI

15 May 2024 – From EuroPCR 2024

Watch this session to learn the best practices for treating aortic stenosis, with a focus on lifetime management. Gain insights into evaluating patient anatomy and clinical presentation to anticipate the need for a second valve, understand different valve designs and their initial selection, and observe a...

Planning for a lifetime starts with choosing the right valve first: from first TAVI to redo-TAVI

Cardiogenic shock in women : different cause, different treatment

15 May 2024 – From EuroPCR 2024

This session will feature selected EuroPCR 2024 Clinical Case submissions focused on cardiogenic shock in women. Attendees will have the opportunity to learn about the proposed diagnoses and treatments, as well as the actual outcomes, for these challenging cases. The session will also include discussions and...

Cardiogenic shock in women : different cause, different treatment

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

14 May 2024 – From EuroPCR 2024

Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

TAVI - Durability and long-term outcomes

20 Nov 2023 – From PCR London Valves 2023

Consult this session to learn more about TAVI durability and long-term outcomes through a selection of abstracts: delve into a comprehensive five-year durability analysis of an intra-annular self-expandable transcatheter aortic bioprosthesis, navigate through the complexities of long-term outcomes associated with prosthesis-patient mismatch following valve-in-valve TAVI, explore...

TAVI - Durability and long-term outcomes

TAVI in complex scenarios - Valve-in-valve TAVI (TAV-in-SAV) - A tailored approach

20 Nov 2023 – From PCR London Valves 2023

This session is designed for those seeking an understanding of critical imaging principles in planning successful TAV-in-SAV procedures. Gain insights into the latest tools for pre-procedural imaging and learn how to develop customized algorithms for selecting transcatheter heart valves in individual patients undergoing TAV-in-SAV interventions.

TAVI in complex scenarios - Valve-in-valve TAVI (TAV-in-SAV) - A tailored approach

TAVI in complex scenarios - Bicuspid aortic valve disease - putting it all together

20 Nov 2023 – From PCR London Valves 2023

After an overview of what is currently known about TAVI in bicuspid aortic valves, follow the analysis of a real-life clinical case, and get tips on how to perform TAVI in a bicuspid aortic valve in 3 different ways: with a self-expanding supra-annular valve, using a...

TAVI in complex scenarios - Bicuspid aortic valve disease - putting it all together

TAVI outcomes - Part 1

19 Nov 2023 – From PCR London Valves 2023

Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...

TAVI outcomes - Part 1

Selecting the right first valve to secure lifetime management

17 May 2023 – From EuroPCR 2023

The treatment of young and less at-risk patients clearly shows that their age, life expectancy and risk factors are essential parameters to be taken into account in the choice of TAVI and therefore it is essential to think about future coronary access after TAVI. Watch the...

EuroPCR 2023 Hotlines / Late-Breaking Trials: TAVI

16 May 2023 – From EuroPCR 2023

Discover the conclusions of various studies and registries about TAVI: 5-year outcomes with the ACURATE neo2 valve: the Neo AS CE-mark study; TAVR in patients with cardiogenic shock which evaluated outcomes of consecutive TAVRs in patients with CS using contemporary SAPIEN 3 and SAPIEN 3 ultra...

TAVI Hotlines EuroPCR2023

Tricuspid and pulmonary interventions

27 Nov 2022 – From PCR London Valves 2022

Watch this series of cases presented at PCR LV 2022 and learn more about Alagille syndrome, how to treat a significant right-to-left shunt after bicaval valve implantation, or analyze transcatheter pulmonary valve implantation in tetralogy of Fallot, among others.

Tricuspid and pulmonary interventions

Valve-in-valve TAVI: session 1

27 Nov 2022 – From PCR London Valves 2022

ViV TAVI in a patient with previous Bentall's operation, ViV for a failed surgical aortic bioprosthesis with a misaligned mitral bioprosthesis, TAVI for severe aortic regurgitation caused by infective endocarditis after homograft surgery, and much more in this PCR LV 2022 session about ViV TAVI!

Valve-in-valve TAVI: session 1

Ensuring optimal TAVI outcomes - LIVE case

27 Nov 2022 – From PCR London Valves 2022

A 75-year-old female with diabetes and history of ischemic stroke 5 years ago presents a symptomatic severe aortic valve stenosis in a small annulus.
After pre-dilatation (18 mm balloon), the operators implant an Acurate neo2 23 mm with a sentinel cerebral embolic protection device. Watch them perform...

Ensuring optimal TAVI outcomes

TAVI procedure with cerebral embolic protection

05 Dec 2019

Discover the replay of this webinar on TAVI with H. Moellmann, O. Husser and P. MacCarthy.

How can I minimize the risk of conduction abnormalities for my TAVI patients?

29 Sep 2021

PCR Webinar on TAVI with H. Möllmann, L. Nombela and S. Toggweiler

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

18 May 2022 – From EuroPCR 2022

What is angiographic SYNTAX score? Are 3VD all the same? What do ESC guidelines recommend? You will find answers to these questions, and many more, in this EuroPCR 2022 session, through which you will learn how to identify the right patient for three-vessel PCI, select the lesions to be...

How to select three-vessel disease patients eligible for PCI and guide the treatment by angiography-derived physiology

Transcatheter mitral edge intervention

17 May 2022 – From EuroPCR 2022

In this session, watch LIVE from Toulouse, France, an edge-to-edge transcatheter mitral valve repair on an 85-year-old male patient with severe primary mitral regurgitation and III NYHA shortness of breath, history of hypertension, NSTEMI in November 2019 resulting in PCI with DES on proximal and distal LADs,...

Transcatheter mitral edge intervention

TAVI in a patient with asymptomatic severe aortic stenosis - Session with LIVE case

17 May 2022 – From EuroPCR 2022

Watch this LIVE demonstration from London, United Kingdom to find out how this asymptomatic, 70-year-old, overweight, previously CABG (205) male patient with permanent atrial fibrillation and unlimited exercise tolerance was treated. 

TAVI valve and implantation technique: the secrets for optimising outcomes

21 Nov 2021 – From PCR London Valves 2021

Join Neil Moat, Helge Möllmann, Lars Søndergaard and Ganesh Manoharan to hear the experience of an account achieve single digit permanent pacemaker implantation, to learn how to preserve coronary access for future patients' treatment, and to see how new product features can reduce paravalvular leak.

#3 - How can I minimize the risk of conduction abnormalities for my TAVI patients?

28 Jun 2021

PCR Webinar on TAVI with H. Möllmann, L. Nombela and S. Toggweiler

Introducing Navitor: a new TAVI solution

18 May 2021 – From EuroPCR 2021

Watch this session presented by Helge Möllmann, Lars Sondergaard, Maurizio Taramasso, Ganesh Manoharan and Dave Smith in order to discuss how to minimise resources needed for your TAVI procedure without compromising safety and efficacy, to demonstrate how to simplify your TAVI procedure, and to examine considerations for lifetime management of your...

Introducing Navitor: a new TAVI solution

A comprehensive experience with image-guided robotic PCI

18 May 2021 – From EuroPCR 2021

Watch this session presented by Jean Fajadet, Bruno Farah, William Wijns, J. Aaron Grantham, Helge Möllmann and Holger Nef in order to understand the value of robotics in daily PCI practice, to learn through user experiences how angiography-based physiology and robotic assistance work together to improve patient...

A comprehensive experience with image-guided robotic PCI

Securing coronary access during and after TAVI

23 Nov 2020 – From PCR Valves e-Course 2020

Watch this session if you want to understand the implications of coronary artery disease in TAVI patients, to learn how device implantation technique could simplify coronary access and to recognize the feasibility of coronary access during and after TAVI.

Transcatheter mitral valve repair for degenerative mitral regurgitation - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this live transmission from EuroPCR 2019 to discover the case of a 87 years-old female, who has been referred for degenerative mitral regurgitation. Watch it now to find out about the treatment's choice!

LIVE demonstration from Rigshospitalet, University of Copenhagen - Copenhagen, Denmark

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions

23 May 2019 – From EuroPCR 2019

Consult this session to learn about the updated perspective on the bleeding definition in interventional cardiology, and antithrombotic treatment regimens in atrial fibrillation patients undergoing PCI or TAVI.

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions